Porto Seguro Earnings Call Transcripts
Fiscal Year 2025
-
Record revenue and net income growth in 2025 driven by diversification, with strong performance across insurance, health, bank, and services. 2026 guidance anticipates further premium growth, improved loss ratios, and higher financial results, supported by operational efficiency and capital management.
-
Record Q3 2025 results with 11% revenue growth, 13% higher net income, and ROA at 23%. Diversified growth across insurance, health, banking, and services, with strong efficiency gains and robust capital position. Competitive pressures in auto and regulatory changes in health are being managed.
-
Q2 2025 saw record revenue and net income, with strong growth across insurance, health, and banking segments. Operational efficiency improved due to integration and diversification, while guidance was updated to reflect higher expected credit losses and stable financial results.
-
Q1 2025 saw record revenue and net income, with all business verticals growing and ROAE at 24%. Diversification, operational efficiency, and strong cash generation supported robust results, while guidance remains conservative amid stable market conditions.
Fiscal Year 2024
-
Q4 2024 saw double-digit revenue and net income growth, record client numbers, and strong performance across insurance, health, banking, and services. Guidance for 2025 is robust, with higher dividend payouts and continued capital discipline, while discontinued operations will no longer impact results.<docu…
-
Q3 2024 saw double-digit revenue and net income growth, led by health, banking, and services, with improved profitability and efficiency across all verticals. Guidance was raised for health and overall revenue, while capital and risk management remain conservative amid a stable competitive environment.
-
Q2 2024 delivered 13.6% revenue growth and strong diversification, despite BRL 274 million in claims from Rio Grande do Sul floods. Adjusted net income rose 2% year-over-year, with robust results across all business lines and guidance unchanged.